Burton J. Goldstein, M.D.
- Emeritus Professor, Department of Public Health Sciences
Burton Goldstein, M. D. is an Emeritus Professor of Psychiatry, Pharmacology & Public Health Sciences at the Miller School of Medicine, University of Miami. He received his M.D. degree from the University of Maryland and completed his psychiatry residency at the University of Miami Jackson Memorial Hospital Center in 1964. Upon completion of his residency training he joined the faculty of the Department of Psychiatry at the School of Medicine. Doctor Goldstein was promoted to Professor and awarded tenure in 1972. He served as Interim Chairman of the Department of Psychiatric and Behavioral Sciences between 1983 and 1986.
In 1994, Dr. Goldstein was selected by Good Housekeeping Magazine as one of the America’s best mental Health Professionals in the treatment of Depression. The Consumers Research Council of America named Doctor Goldstein as one of America’s Top Psychiatrists in the treatment of Depression in their 2002-2004 editions. Dr. Goldstein’s biography appears in Who’s Who in the World, Who’s Who in America & American Men & women of Science and Who’s Who in Medicine and Health care (all in current editions).
Between 1996 and 2011, Doctor Goldstein served as Senior Peer Reviewer and then Medical Director of the Miller School of Medicine, University of Miami Behavioral Health System. He has been a Principal Investigator on numerous federal grants awarded from the National Institute of Mental Health. The National Institute of Drug Abuse & the Office of Education. His funding throughout his nearly 45 years as a Tenured Professor has amounted over $10,000,000 in today’s dollars.
Dr. Goldstein’s major research endeavors have been in clinical psychopharmacology. He is a Board Certified Psychiatrist and has been an examiner for the American Board of Psychiatry & Neurology. Dr. Goldstein is a Life Fellow and Fellow of many psychiatric and pharmacological organizations. He has published extensively in scientific journals and contributed many book chapters in the area of clinical psychopharmacology. He has been a Visiting Professor at numerous national and international academic institutions and has delivered over 650 invited lectures in over 40 countries.
Currently, he also is collaborating with colleagues in the Department of Public Health Sciences in developing research programs to study and evaluate Psychiatric Treatment Outcomes, Recidivism, Enhancing Treatment Adherence and other areas of Public Health interest.